Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Hong Kong · Delayed Price · Currency is HKD 21.72
-0.16 (-0.73%)
Apr 17, 2026, 3:30 PM HKT
HKG:6826 Market Cap
HKG:6826 has a market cap or net worth of 9.34 billion as of April 16, 2026. Its market cap has decreased by -29.93% in one year.
Market Cap
9.34B
Enterprise Value
7.18B
Revenue
2.72B
Ranking
n/a
PE Ratio
18.16
Stock Price
21.72
Market Cap Chart
Since April 30, 2015, HKG:6826's market cap has decreased from 9.34B to 9.34B, a decrease of -0.09%. That is a compound annual growth rate of -0.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 9.34B | -8.19% |
| Dec 31, 2025 | 10.17B | -23.81% |
| Dec 31, 2024 | 13.35B | -24.15% |
| Dec 29, 2023 | 17.60B | 7.10% |
| Dec 30, 2022 | 16.43B | -29.33% |
| Dec 31, 2021 | 23.25B | 40.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Everest Medicines | 14.19B |
| HBM Holdings | 12.10B |
| CARsgen Therapeutics Holdings | 11.84B |
| Lepu Biopharma | 11.19B |
| Alphamab Oncology | 10.85B |
| Guangzhou Innogen Pharmaceutical Group | 9.42B |
| Abbisko Cayman | 9.12B |
| Laekna | 7.32B |